ReviewMetabolism open2025

Deliberating the striking effect of dual GLP-1R and GIPR agonists on "Diabesity" in light of precision medicine and pharmacogenomics.

Angeliki Margoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.